Albemarle — Nov 6, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915913-24-000156
Showing in the filing
Adjusted EBITDA - Q4 2023 average scenario
“$1.6 - $1.8 billion”
Period
FY2024
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 27
Annual run-rate cost and productivity improv…
“$300 million to $400 million”
Annual run-rate cost savings
“$300 million to $400 million”
Global workforce reduction
“6-7%”
Charge related to cost and operating structu… for Q4 FY2024
“a charge primarily related to severance and related benefit costs”
Capital expenditures for FY2025
“$800 million to $900 million”
Total company full-year 2024 net sales for FY2024
“at the lower-end of that range”
Average lithium market price ($/kg LCE) - Re… for FY2024
“$12-15”
Average lithium market price ($/kg LCE) (a) for FY2024
“$12-15”
Average lithium market price ($/kg LCE) - Q4… for FY2024
“~$20”
Average lithium market price ($/kg LCE) - H2… for FY2024
“~$25”
Net sales for FY2024
“$5.5 - $6.2 billion”
Net sales - Recent pricing scenario for FY2024
“$5.5 - $6.2 billion”
Net sales - Q4 2023 average scenario for FY2024
“$6.1 - $6.8 billion”
Net sales for Q4 FY2023
“$6.1 - $6.8 billion”
Net sales - H2 2023 average scenario for FY2024
“$6.9 - $7.6 billion”
Net sales for FY2023
“$6.9 - $7.6 billion”
Adjusted EBITDA - Recent pricing scenario for FY2024
“$0.9 - $1.2 billion”
Adjusted EBITDA (b)(c) for FY2024
“$0.9 - $1.2 billion”
Adjusted EBITDA - Q4 2023 average scenario for FY2024
“$1.6 - $1.8 billion”
Adjusted EBITDA (b)(c) for Q4 FY2023
“$1.6 - $1.8 billion”
Adjusted EBITDA - H2 2023 average scenario for FY2024
“$2.3 - $2.6 billion”
Adjusted EBITDA (b)(c) for FY2023
“$2.3 - $2.6 billion”
Weighted-average common shares outstanding (… for FY2024
“~118 million”
Weighted-average common shares outstanding (… for Q4 FY2023
“~118 million”
Weighted-average common shares outstanding (… for FY2024
“135 - 139 million”
Weighted-average common shares outstanding (… for FY2023
“135 - 139 million”
Capital expenditures for the full-year 2024 for FY2024
“at the lower-end of the prior outlook range of $1.7 billion to $1.8 billion”
Exhibit 99.1 · the passage around this item
… earlier in the release
Total Corporate FY 2024E Including Energy Storage Scenarios Observed market price case (a) Recent pricing Q4 2023 average H2 2023 average Average lithium market price ($/kg LCE) (a) $12-15 ~$20 ~$25 Net sales $5.5 - $6.2 billion $6.1 - $6.8 billion $6.9 - $7.6 billion Adjusted EBITDA (b)(c) $0.9 - $1.2 billion $1.6 - $1.8 billion $2.3 - $2.6 billion Weighted-average common shares outstanding (diluted) (d) ~118 million ~118 million 135 - 139 million (a) Price represents blend of relevant Asia and China market indices for the periods referenced. (b) The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See “Additional Information regarding Non-GAAP Measures” for more information. (c) Presented under updated adjusted EBITDA definition as of 2024. FY23 adjusted EBITDA under updated definition would be $3.5B. See Non-GAAP Reconciliations for further details. (d) Each quarter, Albemarle will report the more dilutive of either: 1) adding the underlying shares in the mandatory to the share count or 2) reducing Albemarle’s net income to common shareholders by the mandatory dividend. The 20-day volume-weighted average common share price will be used in determining the underlying shares to be added to the share count. 2 Third Quarter 2024 Results In millions, ex
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.